{"id":"https://openalex.org/W2963914280","doi":"https://doi.org/10.2174/1381612825666190716111245","title":"P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future","display_name":"P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future","publication_year":2019,"publication_date":"2019-07-23","ids":{"openalex":"https://openalex.org/W2963914280","doi":"https://doi.org/10.2174/1381612825666190716111245","mag":"2963914280","pmid":"https://pubmed.ncbi.nlm.nih.gov/31333097"},"language":"en","primary_location":{"id":"doi:10.2174/1381612825666190716111245","doi":"https://doi.org/10.2174/1381612825666190716111245","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612825666190716111245","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039571006","display_name":"Pobitra Borah","orcid":"https://orcid.org/0000-0003-1047-4552","observed_orcids":["https://orcid.org/0000-0003-1047-4552"]},"institutions":[{"id":"https://openalex.org/I4403928273","display_name":"Pratiksha Institute of Pharmaceutical Sciences","ror":"https://ror.org/00r3bk393","country_code":"IN","type":"education","lineage":["https://openalex.org/I4403928273"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Pobitra Borah","raw_affiliation_strings":["Pratiksha Institute of Pharmaceutical Sciences, Panikhaiti, Chandrapur Road, Guwahati, Assam, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pratiksha Institute of Pharmaceutical Sciences, Panikhaiti, Chandrapur Road, Guwahati, Assam, India","institution_ids":["https://openalex.org/I4403928273"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Satyendra Deka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928273","display_name":"Pratiksha Institute of Pharmaceutical Sciences","ror":"https://ror.org/00r3bk393","country_code":"IN","type":"education","lineage":["https://openalex.org/I4403928273"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Satyendra Deka","raw_affiliation_strings":["Pratiksha Institute of Pharmaceutical Sciences, Panikhaiti, Chandrapur Road, Guwahati, Assam, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pratiksha Institute of Pharmaceutical Sciences, Panikhaiti, Chandrapur Road, Guwahati, Assam, India","institution_ids":["https://openalex.org/I4403928273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056375312","display_name":"Raghu Prasad Mailavaram","orcid":"https://orcid.org/0000-0001-6126-5860","observed_orcids":["https://orcid.org/0000-0001-6126-5860"]},"institutions":[{"id":"https://openalex.org/I100887729","display_name":"Andhra University","ror":"https://ror.org/049skhf47","country_code":"IN","type":"education","lineage":["https://openalex.org/I100887729"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Raghu Prasad Mailavaram","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, Shri Vishnu College of Pharmacy, Vishnupur (Affiliated to Andhra University), Bhimavaram, W.G. Dist., AP, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Shri Vishnu College of Pharmacy, Vishnupur (Affiliated to Andhra University), Bhimavaram, W.G. Dist., AP, India","institution_ids":["https://openalex.org/I100887729"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029780869","display_name":"Pran Kishore Deb","orcid":"https://orcid.org/0000-0002-8650-2874","observed_orcids":["https://orcid.org/0000-0002-8650-2874"]},"institutions":[{"id":"https://openalex.org/I153921779","display_name":"Philadelphia University","ror":"https://ror.org/05mqvn149","country_code":"JO","type":"education","lineage":["https://openalex.org/I153921779"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"Pran Kishore Deb","raw_affiliation_strings":["Faculty of Pharmacy, Philadelphia University, Amman, PO Box-1, 19392, Jordan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Philadelphia University, Amman, PO Box-1, 19392, Jordan","institution_ids":["https://openalex.org/I153921779"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5056375312"],"corresponding_institution_ids":["https://openalex.org/I100887729"],"apc_list":null,"apc_paid":null,"fwci":0.5269,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.38815789,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"25","issue":"26","first_page":"2792","last_page":"2807"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine-receptor-agonists","display_name":"adenosine receptor agonists","score":0.9169999957084656},{"id":"https://openalex.org/keywords/adenosine-receptor-antagonists","display_name":"adenosine receptor antagonists","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-candidates","display_name":"drug candidates","score":0.531000018119812},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.9459999799728394},{"id":"https://openalex.org/keywords/new-chemical-entities","display_name":"new chemical entities","score":0.7789999842643738},{"id":"https://openalex.org/keywords/adenosine-a1-receptor","display_name":"adenosine A1 receptor","score":0.8050000071525574},{"id":"https://openalex.org/keywords/adenosine-a2a-receptor","display_name":"adenosine A2A receptor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/adenosine-a2b-receptor","display_name":"adenosine A2B receptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/a3-adenosine-receptor","display_name":"A3 adenosine receptor","score":1.0},{"id":"https://openalex.org/keywords/regadenoson","display_name":"regadenoson","score":0.9139999747276306},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.8349999785423279},{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.8870000243186951},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.9160000085830688},{"id":"https://openalex.org/keywords/cancer","display_name":"cancer","score":0.8059999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.746269941329956},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.722978949546814},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5426313281059265},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5358653664588928},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4966345429420471},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.43771129846572876},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.4292450249195099},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2198893129825592},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.1204330325126648}],"mesh":[{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018047","descriptor_name":"Receptors, Purinergic P1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058906","descriptor_name":"Purinergic P1 Receptor Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D058915","descriptor_name":"Purinergic P1 Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2174/1381612825666190716111245","doi":"https://doi.org/10.2174/1381612825666190716111245","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612825666190716111245","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:31333097","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31333097","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":83,"referenced_works":["https://openalex.org/W186512590","https://openalex.org/W1569222873","https://openalex.org/W1594028947","https://openalex.org/W1951726957","https://openalex.org/W1967487604","https://openalex.org/W1968238061","https://openalex.org/W1975391500","https://openalex.org/W1979406691","https://openalex.org/W1985598247","https://openalex.org/W1987291608","https://openalex.org/W1990269363","https://openalex.org/W1992386184","https://openalex.org/W1995698717","https://openalex.org/W2008624230","https://openalex.org/W2017300871","https://openalex.org/W2020128067","https://openalex.org/W2022472954","https://openalex.org/W2035635330","https://openalex.org/W2057956109","https://openalex.org/W2079732066","https://openalex.org/W2088277236","https://openalex.org/W2093113166","https://openalex.org/W2093777829","https://openalex.org/W2094296572","https://openalex.org/W2097253015","https://openalex.org/W2098624980","https://openalex.org/W2104088325","https://openalex.org/W2106861254","https://openalex.org/W2109628462","https://openalex.org/W2111551673","https://openalex.org/W2111788554","https://openalex.org/W2116238347","https://openalex.org/W2117349332","https://openalex.org/W2122063078","https://openalex.org/W2129211276","https://openalex.org/W2136502909","https://openalex.org/W2140969958","https://openalex.org/W2143644773","https://openalex.org/W2150021667","https://openalex.org/W2161149962","https://openalex.org/W2165742786","https://openalex.org/W2166864345","https://openalex.org/W2167158961","https://openalex.org/W2181200527","https://openalex.org/W2197759468","https://openalex.org/W2282791812","https://openalex.org/W2304392049","https://openalex.org/W2334581933","https://openalex.org/W2335312575","https://openalex.org/W2411952446","https://openalex.org/W2468146224","https://openalex.org/W2477146316","https://openalex.org/W2496347914","https://openalex.org/W2507391290","https://openalex.org/W2520297993","https://openalex.org/W2591082182","https://openalex.org/W2603986418","https://openalex.org/W2610902381","https://openalex.org/W2612314923","https://openalex.org/W2613677688","https://openalex.org/W2753394183","https://openalex.org/W2765608900","https://openalex.org/W2767731740","https://openalex.org/W2775465457","https://openalex.org/W2784844917","https://openalex.org/W2789075584","https://openalex.org/W2789333969","https://openalex.org/W2792332633","https://openalex.org/W2794597614","https://openalex.org/W2803288586","https://openalex.org/W2805539079","https://openalex.org/W2809493642","https://openalex.org/W2883059756","https://openalex.org/W2898890542","https://openalex.org/W2918371734","https://openalex.org/W2919167160","https://openalex.org/W2920944046","https://openalex.org/W2921155111","https://openalex.org/W2938577765","https://openalex.org/W2945218965","https://openalex.org/W2945340895","https://openalex.org/W2950005440","https://openalex.org/W3014847176"],"related_works":["https://openalex.org/W2121975625","https://openalex.org/W2928555551","https://openalex.org/W2018692338","https://openalex.org/W4250788208","https://openalex.org/W1980210597","https://openalex.org/W2126664643","https://openalex.org/W2150021667","https://openalex.org/W2124403994","https://openalex.org/W2178156827","https://openalex.org/W4384461434"],"abstract_inverted_index":{"BACKGROUND:":[0],"Adenosine":[1],"mediates":[2],"various":[3,41,85,143],"physiological":[4],"and":[5,18,25,72,79,106,115,135,157,167,174,189,206],"pathological":[6],"conditions":[7],"by":[8,171],"acting":[9],"on":[10],"its":[11,36],"four":[12],"P1":[13,23,146,193],"receptors":[14,24,53,147],"(A1,":[15],"A2A,":[16],"A2B":[17],"A3":[19],"receptors).":[20],"Omnipresence":[21],"of":[22,32,68,97,126,145,151,163,192],"their":[26,82,112,136],"activation,":[27],"exert":[28],"a":[29,215],"wide":[30],"range":[31],"biological":[33],"activities.":[34],"Thus,":[35],"modulation":[37],"is":[38,92,180],"implicated":[39],"in":[40,74,84,209],"disorders":[42],"like":[43],"Parkinson's":[44],"disease,":[45],"asthma,":[46],"cardiovascular":[47],"disorders,":[48],"cancer":[49],"etc.":[50],"Hence":[51],"these":[52],"have":[54,102,131,153],"become":[55],"an":[56,95,181],"interesting":[57],"target":[58],"for":[59,81],"the":[60,75,127,172,185,207],"researchers":[61],"to":[62,93,183,217],"develop":[63],"potential":[64],"therapeutic":[65,204,222],"agents.":[66,223],"Number":[67],"molecules":[69],"were":[70],"designed":[71],"developed":[73],"past":[76],"few":[77],"years":[78],"evaluated":[80],"efficacy":[83],"disease":[86],"conditions.":[87],"OBJECTIVE:":[88],"The":[89],"main":[90],"objective":[91],"provide":[94],"overview":[96],"new":[98],"chemical":[99,140],"entities":[100,141],"which":[101,130,196,210],"crossed":[103,154],"preclinical":[104,155],"studies":[105,156],"reached":[107,158],"clinical":[108,133,159,199],"trials":[109,134,160,200],"stage":[110],"following":[111],"current":[113,124,186],"status":[114,125],"future":[116,191],"prospective.":[117],"METHODS:":[118],"In":[119],"this":[120],"review":[121,179],"we":[122],"discuss":[123],"drug":[128],"candidates":[129],"undergone":[132],"prospects.":[137],"RESULTS:":[138],"Many":[139],"targeting":[142],"subtypes":[144],"are":[148,169,197],"patented;":[149],"twenty":[150],"them":[152,164],"stage.":[161],"Two":[162],"viz":[165],"adenosine":[166],"regadenoson":[168],"approved":[170],"Food":[173],"Drug":[175],"Administration.":[176],"CONCLUSION:":[177],"This":[178],"attempt":[182],"highlight":[184],"status,":[187],"progress":[188],"probable":[190],"receptor":[194],"ligands":[195],"under":[198],"as":[201],"promising":[202],"novel":[203,221],"agents":[205],"direction":[208],"research":[211],"should":[212],"proceed":[213],"with":[214,220],"view":[216],"come":[218],"out":[219]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2019-07-30T00:00:00"}